COVID-19
It will take months or possibly years to definitively appreciate how the COVID-19 pandemic will affect people with
Focus on LRRK2 inhibition – implications for idiopathic Parkinson’s
A new preclinical study has shown that LRRK2 inhibition in an animal model of Parkinson’s can improve lysosomal health and reduce alpha synuclein accumulation in dopaminergic neurons.
Gut infection triggers Parkinson’s-like symptoms in mice
PINK1 may also protect cells and the brain from autoimmune attack
Discovering genetics of age at onset
Using the largest ever genetics dataset
Parkinson Matters: A Call to Action
Discrepancies between end of life preferences
Global Parkinson’s Pandemic
Parkinson’s is now held to be the fastest growing neurological disorder.
Powered by
Science with
